-
New Drugs for an Elusive Cancer Target
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
-
Clinical Trials: An African American Survivor’s Experience
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
-
A Switch From Intravenous to Oral Chemo?
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.
by Ashley P. Taylor
-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
Treating Fear of Recurrence
Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.
by Jon Kelvey
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
HIV Can Worsen Cancer Treatment Outcomes
People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
Helping Cancer Survivors Sleep
A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.
by Cheryl Platzman Weinstock
-
So You Want to Serve on a Scientific Review Panel?
Cancer patient advocates who review research proposals can provide valuable perspective.
by Bob Riter, Monica Vakiner and Carole Baas
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event
Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
Cancer Talk
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose
Lung Cancer Patients Face Worse Survival After Wildfire ExposureResearchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
by Sandra Gordon
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
From the AACR
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More Women
An innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
-
From the Bench: Creative Approaches in Cancer Research
Insects that smell cancer, new CRISPR delivery tools, and a cancer-fighting battery—the AACR's new blog series, From the Bench, highlights creative approaches in cancer research.
Video
Ricki Fairley: Surviving and Thriving After Triple Negative Breast Cancer
